Work from the Unit's Social Science programme has been listed in the Directory of Research on Ageing in Africa: 2004-2015.

The Ring Study and ASPIRE - have shown that a monthly vaginal ring containing the antiretroviral drug (ARV) dapivirine can safely help prevent HIV-1 infection in women and may be an important HIV p

On 29th October 2015, the Unit launched the "HIV prevention and research in Uganda Police Force" programme.

The MRC/UVRI Uganda Research Unit on AIDS has been recognized as a leader in HIV & AIDS Research at the inaugural HIV/AIDS Leadership Awards.

Seven leading African researchers are the recipients of major funding from the Wellcome Trust and the Department for International Development (DFID) to establish cutting-edge research and training

Three graphic novels produced by the ARROW Young Lives study team are now available to read online.

Researchers from the London School of Hygiene and Tropical Medicine (LSHTM) presented social science findings from the ARROW and BREATHER trials.

On 13th August 2015, the Uganda Virus Research Institute (UVRI) commissioned a training center to promote research capacity building for Scientists from Uganda and the region.

Type 2 diabetes (T2D) is a major cause of premature mortality and morbidity worldwide and thus poses a significant public health challenge.

High risk populations such as commercial sex workers and fisher folk are being prepared for future HIV vaccine trials.

Final results from two landmark studies bolstered the scientific case for initiating HIV treatment soon after diagnosis, and an additional study shed new light on the non-daily use of pre-exposure

Stopping cotrimoxazole prophylaxis increases the risk of serious bacterial infections and malaria, even at high CD4 cell counts, in people taking antiretroviral therapy in Uganda, results of a rand